医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

ResearchDx, the Leading Contract Diagnostics Organization, Expands Operations into India

2013年11月25日 AM09:55
このエントリーをはてなブックマークに追加


 

MUMBAI

ResearchDx, LLC of Irvine, California, USA today announced an expansion of its operations to focus on the important Indian biopharmaceutical and diagnostics markets.

As part of this initiative, ResearchDx will be presenting at the BioPharma India Convention 2013 Meeting in Mumbai, India, held November 25th-26th. “We are proud to be involved as a sponsor of the BioPharma India Convention 2013 meeting. This meeting brings together the key diagnostics and biopharmaceutical companies in the region and is the ideal venue to highlight our services” said Dr. Philip Cotter, Principal and Co-Founder of ResearchDx.

As a Contract Diagnostics Organization, ResearchDx is targeting two major areas for Indian clients. “We can provide a strategic partnership to Indian companies looking to develop companion diagnostics or in vitro diagnostic products for the local, US or European markets. We provide a full range of companion diagnostics and in vitro diagnostics services” said Dr. Mathew Moore, Co-Founder and Principal at ResearchDx.

In addition, ResearchDx provides comprehensive services to assist International Clinical Laboratories obtain US CLIA certification, as well as various additional Clinical Laboratory accreditations such as ISO or College of American Pathologists (CAP). “International CLIA certification, and ISO or CAP accreditation provides our clients with a competitive edge. These licensures have enabled our clients to successfully compete for multi-national based clinical trial studies,” said Dr. Philip Cotter.

ResearchDx is the leading Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. The company provides comprehensive, integrated, flexible services for the in vitro diagnostic development process. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx offers the services and solutions to meet complex diagnostics development needs. ResearchDx’s primary service areas include assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting. Additional information is available at www.researchdx.com.

CONTACT

Media:
ResearchDx
Philip D. Cotter, PhD, FACMG,
FFSc(RCPA)
866-225-9195 / 510-332-0477
pcotter@researchdx.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
  • PotNetwork Holdings, Inc.第三季度业绩创纪录,营收超过610万美元
  • ポットネットワーク・ホールディングスが610万ドルを超える収益で過去最高の第3四半期を終える
  • ポットネットワーク・ホールディングスがSEC報告会社となるためにフォーム10を提出
  • Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and Forged Board Member Signatures